These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6980372)

  • 1. Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis.
    Lebrec D; Bernuau J; Rueff B; Benhamou JP
    N Engl J Med; 1982 Aug; 307(9):560. PubMed ID: 6980372
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices.
    Elder CA; Restino MS
    Clin Pharm; 1992 Apr; 11(4):337-41. PubMed ID: 1563229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal varices prior to bleeding. Diagnosis and physiological and therapeutic effects of propranolol in cirrhosis.
    Bendtsen F
    Dan Med Bull; 1993 Jun; 40(3):306-16. PubMed ID: 8339602
    [No Abstract]   [Full Text] [Related]  

  • 4. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.
    Pascal JP; Cales P
    N Engl J Med; 1987 Oct; 317(14):856-61. PubMed ID: 3306385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol withdrawal and variceal hemorrhage.
    Alabaster SL; Gogel HK; McCarthy DM
    JAMA; 1983 Dec; 250(22):3047. PubMed ID: 6606054
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.
    Poynard T; Calès P; Pasta L; Ideo G; Pascal JP; Pagliaro L; Lebrec D
    N Engl J Med; 1991 May; 324(22):1532-8. PubMed ID: 1674104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol].
    López Fuerte F; Cárdenas Rojas JA; Esquivel López A; Perches Vega A
    Rev Gastroenterol Mex; 1986; 51(4):187-90. PubMed ID: 3502507
    [No Abstract]   [Full Text] [Related]  

  • 8. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.
    Lebrec D; Poynard T; Hillon P; Benhamou JP
    N Engl J Med; 1981 Dec; 305(23):1371-4. PubMed ID: 7029276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propranolol in the prevention of digestive bleeding in cirrhotic patients].
    Sotto A; Castro R; Glez Cansino J
    Acta Gastroenterol Latinoam; 1989; 19(1):15-20. PubMed ID: 2690549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.
    Burroughs AK; Jenkins WJ; Sherlock S; Dunk A; Walt RP; Osuafor TO; Mackie S; Dick R
    N Engl J Med; 1983 Dec; 309(25):1539-42. PubMed ID: 6361553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of digestive hemorrhage recurrence in hepatic cirrhosis with propranolol. A 4 years' follow-up study].
    Jirón MI; Soto JR; Wolff C; Armas R
    Rev Med Chil; 1993 Feb; 121(2):133-8. PubMed ID: 8303108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol and hemorrhage from esophageal varices.
    Smythe WR
    N Engl J Med; 1988 Apr; 318(15):994-5. PubMed ID: 3258408
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding?
    Senzolo M; Fries W; Buda A; Pizzuti D; Nadal E; Sturniolo GC; Burroughs AK; D'Incà R
    Am J Gastroenterol; 2009 Dec; 104(12):3115-6. PubMed ID: 19956145
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing hemorrhage from esophageal varices.
    Bass NM
    N Engl J Med; 1987 Oct; 317(14):893-5. PubMed ID: 2888019
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexisting gastric varices should not preclude prophylactic ligation of large esophageal varices in cirrhosis.
    Schepke M; Biecker E; Appenrodt B; Heller J; Sauerbruch T
    Digestion; 2009; 80(3):165-9. PubMed ID: 19776579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis of esophageal variceal bleeding in cirrhosis.
    Bellot P; García-Pagán JC; Abraldes JG; Bosch J
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):532-40. PubMed ID: 18456445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bleeding varices in cirrhosis: a critical examination.
    Resnick RH
    Scand J Gastroenterol; 1975; 10(7):673-8. PubMed ID: 1103270
    [No Abstract]   [Full Text] [Related]  

  • 18. Variceal band ligation versus propranolol for primary prophylaxis of variceal bleeding in cirrhosis.
    Gawrieh S; Shaker R
    Curr Gastroenterol Rep; 2005 Jun; 7(3):175-6. PubMed ID: 15913473
    [No Abstract]   [Full Text] [Related]  

  • 19. Precipitation of hepatic encephalopathy by propranolol in cirrhosis.
    Tarver D; Walt RP; Dunk AA; Jenkins WJ; Sherlock S
    Br Med J (Clin Res Ed); 1983 Aug; 287(6392):585. PubMed ID: 6411235
    [No Abstract]   [Full Text] [Related]  

  • 20. [How many cirrhotic patients may receive propranolol after digestive hemorrhage?].
    Silvain C; Chauvin C; Verneau A; Carretier M; Beauchant M
    Gastroenterol Clin Biol; 1985 Oct; 9(10):670-3. PubMed ID: 3877654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.